Dave Johnson

Executive Chairman of the Board, HyperMed Imaging, Inc.

Dave Johnson is executive Chairman for HyperMed Imaging, Inc.  Mr. Johnson is an accomplished medical device executive with over 35 years of experience.

Prior to joining HyperMed, Mr. Johnson has held many senior executive and board positions with large market-leading companies as well as emerging companies with innovative medical devices.  He was Chief Executive Officer and on the Board of Directors of Alliqua Biomedical, a Nasdaq-traded company.  He was also the Chief Executive Officer of Convatec Inc., together with being a member of the Board of Directors.  During this time Mr. Johnson stewarded the sale of Convatec from Bristol-Myers Squibb to Private Equity for $4.1B.  He was also on the Board of Omni Life Sciences and was a part of the team that sold the company to Permira, a leading European Private Equity Company.  Mr. Johnson also served on the board of the Advanced Medical Technology Association, where he chaired the Global Wound Sector Team.

Mr. Johnson has worked and lived in three countries, and managed global markets for over 20 years.  His knowledge of the Device industry and global M&A transactions globally have allowed him to lead over 25 transactions in both the mid- and micro-cap space.  He also raised capital for both mid- and micro-cap companies in the form of public and private transactions from corporate bonds to private equity deals.

Mr. Johnson received an undergraduate business degree in marketing from the North Alberta Institute of Technology in Edmonton, Alberta, Canada; completed the INSEAD Advanced Management Program in Fontainebleau, France; and is a Fellow from the Wharton School, at the University of Pennsylvania.